会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PROCESS FOR PREPARING ANTHRACYCLINONES
    • 制备蒽醌的方法
    • WO1990009974A1
    • 1990-09-07
    • PCT/EP1990000334
    • 1990-02-28
    • FARMITALIA CARLO ERBA S.R.L.CABRI, WalterCANDIANI, IlariaDE BERNARDINIS, SilviaFRANCALANCI, Franco
    • FARMITALIA CARLO ERBA S.R.L.
    • C07C50/38
    • C07C46/00Y02P20/55C07C50/38
    • 4-Substituted anthracyclinones of general formula (I), wherein R represents a hydrogen atom or a COOR1 group in which R1 may be a hydrogen atom or an optionally substituted C1-C10 alkyl group, which are intermediates in the preparation of antitumor anthracycline glycosides, are prepared by: (i) (a) reacting a 4-demethyl-4-sulfonyl-7-deoxy-13-dioxolanyl daunomycinone of formula (V), wherein R' represents an alkyl group having from 1 to 10 carbon atoms optionally substituted by one or more halogen atoms or an aryl group optionally substituted by halogen, alkyl, alkoxy or nitro, in a reducing environment with a catalytic amount of a compound of formula (VIII): MLnL'm, wherein M represents a transition metal atom, L and L', which may be the same or different, each represents an anion or a neutral molecule and n and m may vary from 0 to 4, such as to obtain a compound of formula (VII), wherein R represents hydrogen; or (b) carbonylating a 4-demethyl-4-sulfonyl-7-deoxy-13-dioxolanyl daunomycinone of formula (V) as defined above, with carbon monoxide in the presence of a nucleophile R1OH, wherein R1 is as defined above, an organic or inorganic base and as catalyst a compound of formula (VIII) as defined above, such as to obtain a compound of formula (VII) as shown above wherein R represents a COOR1 group; and (ii) introducing an α-hydroxy group at the 7-position and removing the 13-oxo protecting group by acid hydrolysis from the resultant compound of formula (VII).
    • 2. 发明专利
    • SK278225B6
    • 1996-04-03
    • SK95890
    • 1990-02-28
    • CABRI WALTERCANDIANI ILARIADE BERNARDINIS SILVIAFRANCALANCI FRANCO
    • CABRI WALTERCANDIANI ILARIADE BERNARDINIS SILVIAFRANCALANCI FRANCO
    • B01J31/12C07B61/00B01J27/128C07C46/00C07C49/423C07C49/727C07C50/36C07C50/38
    • METHOD FOR PREPARATION OF ANTHRACYCLINONES The preparation method of anthracyclinones of the general formula I, wherein R means group of the formula COOR1, in which R1 means a hydrogen atom or methyl, resides in following: in the first stage the 13-keto group of the 4-demethyl-3- -deoxydaunomycinone is protected by working up with the ethylene glycol; in the second stage the resultant 4-demethyl-13- -dioxolanyl-7-deoxydaunomycinone reacts with the sulphonatic agent of the formula R'-SO2-X, in which X means the halogene atom or the group of the formula -O-SO2-R' and R' means the trifluoromethyl, p-fluorophenyl or p-tolyl group; in the third stage the resultant 4-demethyl-13-dioxolanyl-7- -deoxydaunomycinone of the general formula V reacts with the nucleophilic agent of the general formula R1OH in which R1 has a meaning listed above, and with the carbon monoxyde under presence of the triethylamine and the catalitic amount of the palladium complex with chelating ligand; and in the fourth stage the resultant 4-demethyl-4-carboxyalkyl-7-deoxy-13- -dioxolanyldaunomycinone of the general formula VII reacts with the bromine solution in the carbon tetrachloride for introduction of the alpha-hydroxy group into the position 7 of the general formula VII compound, then the 13-dioxolanyl protective group is removal and, after chromatographic treatment the required pure compound of the general formula I is obtained.